SPIE.PA
SPIE.PA
FR0012757854
SPIE
Loading chart...
Elevated Business & Solvency Risk

Caution: In addition to price volatility, there are balance sheet risks due to higher debt or weaker liquidity (Health Score: 50/100).

Volatility Risk

Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.

Volatility Risk Score
6/7 High
6 / 7 SRI Price Fluctuation & Beta

Very high volatility or fundamental risks. Significant loss potential; strictly for aggressive investors. Moves noticeably less than the broader market (0.8x).

Beta (Market Relation)
0.76x
Defensive
Volatility (5Y p.a.)
25.0% p.a.
5-Year Horizon
Max Drawdown (5Y)
-24.0%
5-Year Horizon
Sharpe Ratio
0.56
Return / Risk
Speculative / High Risk: Score Basis:

Multi-Horizon Risk & Performance Matrix

Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.

High Volatility
Timeframe
Volatility (p.a.)
Max Drawdown
Sharpe Ratio
Return (p.a.)
1 Year — — — -9.6%
3 Years 25.7% -24.0% 0.52 +15.9%
5 Years 25.0% -24.0% 0.56 +16.4%
10 Years 30.2% -69.9% 0.21 +8.9%

Automated Risk & Health Notes (Red Flags)

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Strong cyclicality: The business model is sensitive to economic downturns.
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (25.0% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -69.9% in the extended horizon.

Corporate Governance & ISS Scores

Shareholder rights, board structure and audit safety (Scale 1 = Low Risk, 10 = High Risk)
Overall Governance Risk
1 ISS Score: 1 / 10
Audit Risk
1 ISS Score: 1 / 10
Board Risk
1 ISS Score: 1 / 10
Short Ratio
-
ende